HILDEN, Germany & GERMANTOWN, Md,--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAstat-Dx Viral Vesicular Panel RUO, the first syndromic ...
MolecuLight Platform is Becoming the Standard-of-Care for Real-Time Imaging of Elevated Bacterial Burden in Wounds Across All Wound Care Settings TORONTO, Oct. 14, 2021 /PRNewswire/ - MolecuLight Inc.
PITTSBURGH, April 29, 2025 /PRNewswire/ - MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for rapid detection of infection causing bacteria in wounds, and DocNow, an ...
PITTSBURGH, Jan. 29, 2026 /PRNewswire/ - MolecuLight today announced that its MolecuLightDX® wound measurement has been qualified by the U.S. Food and Drug Administration (FDA) as a Medical Device ...
Clinicians Recently Performed the 100,000th Procedure Implanting an ICD Equipped with DX Technology – the World's Only Single-Lead ICD System Providing Direct Atrial Sensing BERLIN, Jan. 29, 2024 ...
PITTSBURGH, April 29, 2025 /PRNewswire/ - MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for rapid detection of infection causing bacteria in wounds, and DocNow, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results